For research use only. Not for therapeutic Use.
(6-)ε-Aminocaproic acid (Cat No.:A000735) is an antifibrinolytic agent used to prevent and control excessive bleeding in various medical conditions. It works by inhibiting plasminogen activators and preventing the conversion of plasminogen to plasmin, an enzyme that dissolves blood clots. EACA is effective in treating bleeding disorders such as hemophilia, and during surgical procedures where excessive bleeding is a risk. It is administered orally or intravenously. Common side effects include nausea, diarrhea, and dizziness. EACA’s ability to stabilize blood clots makes it a valuable tool in managing hemorrhagic conditions.
Catalog Number | A000735 |
CAS Number | 60-32-2 |
Synonyms | NA |
Molecular Formula | C6H13NO2 |
Purity | ≥95% |
Target | Disease Research Fields |
Storage | 3 years -20C powder |
IUPAC Name | 6-aminohexanoic acid |
InChI | InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9) |
InChIKey | SLXKOJJOQWFEFD-UHFFFAOYSA-N |
SMILES | C(CCC(=O)O)CCN |